
Please try another search
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories. The Company operates through two segments: the Clinical Services Segment and the Pharma Services Segment. The Clinical Services segment provides various clinical testing services to community-based pathology practices, oncology practices, hospital pathology labs, reference labs, and academic centers with reimbursement from various payers, including client direct billing, commercial insurance, Medicare and other government payers, and patients. The Pharma Services segment supports pharmaceutical firms in their drug development programs by providing testing services and data analytics for clinical trials and research. It offers testing services, which include cytogenetics, fluorescence in-situ hybridization (FISH), flow cytometry, immunohistochemistry (IHC) and digital imaging, molecular testing and morphologic analysis. It operates testing laboratories in United States, Europe and Asia.
Name | Age | Since | Title |
---|---|---|---|
Alison L. Hannah | 61 | 2015 | Member of Scientific Advisory Board & Independent Director |
Bruce K. Crowther | 70 | 2014 | Independent Director |
Stephen M. Kanovsky | 59 | 2017 | Independent Director |
Michael A. Kelly | 65 | 2020 | Independent Director |
James R. Downing | - | 2021 | Member of Scientific Advisory Board |
Rachel A. Stahler | 46 | 2020 | Independent Director |
Steven T. Rosen | - | 2021 | Member of Scientific Advisory Board |
Mark A. Rubin | - | 2021 | Member of Scientific Advisory Board |
Brunangelo Falini | - | 2021 | Scientific Advisors |
Gregory P. Hess | 65 | 2021 | Member of Scientific Advisory Board |
Bernard A. Fox | 68 | 2021 | Member of Scientific Advisory Board |
Riccardo Dalla-Favera | 70 | 2021 | Member of Scientific Advisory Board |
Razelle Kurzrock | - | 2021 | Member of Scientific Advisory Board |
Lynn A. Tetrault | 59 | 2015 | Independent Chair of the Board |
Christopher Michael Smith | 60 | 2022 | CEO & Director |
David Brian Perez | 64 | 2022 | Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review